Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 16/20 | 0.92 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.92 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.70 |
| ▸ | CA1 | P00915 | 1/20 | 0.60 |
| ▸ | CA2 | P00918 | 1/20 | 0.60 |
| ▸ | CA9 | Q16790 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL213881 | 0.96 | PTGS2 (1.00) | PTGS2PTGS1CYP2C9CA1CA2 | |
| SCHEMBL8113323 | 0.96 | PTGS2 (1.00) | PTGS2PTGS1CYP2C9CA1CA2 | |
| SCHEMBL212983 | 0.93 | PTGS2 (0.83) | PTGS2PTGS1CYP2C9CA1CA2 | |
| SCHEMBL8121503 | 0.93 | PTGS2 (0.83) | PTGS2PTGS1CYP2C9CA1CA2 | |
| SCHEMBL216745 | 0.90 | PTGS2 (0.89) | PTGS2PTGS1CYP2C9CA1CA2 | |
| SCHEMBL212919 | 0.87 | CYP2C9 (0.90) | PTGS2PTGS1CYP2C9CA1CA2 | |
| SCHEMBL5698697 | 0.87 | PTGS2 (0.88) | PTGS2PTGS1CYP2C9SMN1; SMN2CHRNA7 | |
| SCHEMBL8422275 | 0.86 | PTGS2 (0.82) | PTGS2PTGS1CYP2C9 | |
| SCHEMBL18826381 | 0.86 | PTGS2 (0.82) | PTGS2PTGS1CYP2C9CA1CA2 | |
| SCHEMBL8423896 | 0.86 | PTGS2 (0.82) | PTGS2PTGS1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0833622-B8 | COMPOSITIONS COMPRISING A CYCLOOXYGENASE-2 INHIBITOR AND A 5-LIPOXYGENASE INHIBITOR | SEARLE & CO (US) | 2005-10-12 | — | — | EP | claimed |
| JP-2001503395-A | — | — | 2001-03-13 | — | — | JP | claimed |
| EP-0932402-A1 | METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE TREATMENT AND PREVENTION OF NEOPLASIA | G.D. SEARLE & CO. (US) | 1999-08-04 | — | — | EP | claimed |
| WO-1998016227-A9 | METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE TREATMENT AND PREVENTION OF NEOPLASIA | — | 1998-07-30 | — | — | WO | claimed |
| WO-1998016227-A1 | METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE TREATMENT AND PREVENTION OF NEOPLASIA | G.D. SEARLE & CO. (US) | 1998-04-23 | — | — | WO | claimed |
| EP-0833622-A1 | COMPOSITIONS COMPRISING A CYCLOOXYGENASE-2 INHIBITOR AND A 5-LIPOXYGENASE INHIBITOR | G.D. SEARLE & CO. (US) | 1998-04-08 | — | — | EP | claimed |
| WO-1996041626-A1 | COMPOSITIONS COMPRISING A CYCLOOXYGENASE-2 INHIBITOR AND A 5-LIPOXYGENASE INHIBITOR | G.D. SEARLE & CO. (US) | 1996-12-27 | — | — | WO | claimed |
| EP-0833622-B8 | COMPOSITIONS COMPRISING A CYCLOOXYGENASE-2 INHIBITOR AND A 5-LIPOXYGENASE INHIBITOR | SEARLE & CO (US) | 2005-10-12 | — | — | EP | disclosed |
| EP-0833622-A1 | COMPOSITIONS COMPRISING A CYCLOOXYGENASE-2 INHIBITOR AND A 5-LIPOXYGENASE INHIBITOR | G.D. SEARLE & CO. (US) | 1998-04-08 | — | — | EP | disclosed |
| WO-1996041626-A1 | COMPOSITIONS COMPRISING A CYCLOOXYGENASE-2 INHIBITOR AND A 5-LIPOXYGENASE INHIBITOR | G.D. SEARLE & CO. (US) | 1996-12-27 | — | — | WO | disclosed |